Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Boston Scientific Corporation

Market Cap 67.78B 59.67B 55.04B 51.48B 96.45B 6,389B 98.25B 661B 256B 3,151B 254B 249B 10,965B P/E 2026 *
16.8x
P/E 2027 * 15.9x
Enterprise Value 74.94B 65.97B 60.85B 56.91B 107B 7,063B 109B 731B 283B 3,484B 281B 275B 12,123B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.08x
Free-Float
84.76%
Yield 2026 *
-
Yield 2027 * -
1 day-1.93%
1 week-0.80%
Current month-7.70%
1 month-22.64%
3 months-34.57%
6 months-53.61%
Current year-53.24%
1 week 44.05
Extreme 44.05
45.83
1 month 44.05
Extreme 44.05
58.14
Current year 44.05
Extreme 44.05
100.9
1 year 44.05
Extreme 44.05
109.5
3 years 44.05
Extreme 44.05
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 2011-10-31
Director of Finance/CFO 52 2025-06-29
Chief Tech/Sci/R&D Officer - 2009-08-31
Director TitleAgeSince
Chairman 61 2016-05-02
Director/Board Member 74 2014-02-28
Director/Board Member 74 2016-04-14
Date Insider Type Main position Quantity % Market Cap.
05-27Don

Chief Executive Officer

-386,755 0.0261%
05-19Buy

Director

3,580 0.0002%
05-19Buy

Director

1,770 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.93%-0.80%-57.17%-16.65% 67.78B
+4.47%+5.93%+20.95%-6.31% 174B
+0.07%+0.27%-22.91%+24.02% 143B
+5.50%+6.00%-4.58%-20.79% 127B
+2.91%+2.98%+17.69%-0.25% 50.07B
-0.84%-1.21%-27.01%-32.27% 43.84B
+3.69%+5.54%+11.54%+10.86% 35.78B
+3.73%+3.77%+6.82%+42.63% 35.07B
+1.95%+6.31%-9.68%-16.44% 28.99B
+2.39%+4.95%-23.60%-8.84% 27.62B
Average +2.21%-1.61%-8.80%-2.41% 73.3B
Weighted average by Cap. +2.54%-2.01%-6.35%-2.32%

Financials

2026 *2027 *
Net sales 21.59B 19.01B 17.53B 16.4B 30.73B 2,035B 31.3B 211B 81.62B 1,004B 81.07B 79.31B 3,493B 23.37B 20.57B 18.98B 17.75B 33.25B 2,203B 33.87B 228B 88.33B 1,086B 87.73B 85.83B 3,780B
Net income 3.88B 3.41B 3.15B 2.94B 5.52B 365B 5.62B 37.83B 14.65B 180B 14.56B 14.24B 627B 4.12B 3.63B 3.34B 3.13B 5.86B 388B 5.97B 40.2B 15.57B 192B 15.46B 15.13B 666B
Net Debt 7.16B 6.3B 5.81B 5.44B 10.19B 675B 10.38B 69.86B 27.06B 333B 26.88B 26.3B 1,158B 4.08B 3.59B 3.31B 3.1B 5.8B 384B 5.91B 39.78B 15.41B 190B 15.3B 14.97B 659B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
26-06-24 US$44.63 -2.14% 9,122,360
26-06-23 US$45.60 +2.86% 18,696,071
26-06-22 US$44.33 -2.12% 16,784,721
26-06-18 US$45.29 +0.76% 30,854,998
26-06-17 US$44.95 -4.20% 20,824,302
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
45.60USD
Average target price
75.86USD
Spread / Average Target
+66.35%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!